These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 19655410

  • 1. (-)-Epigallocatechin-3-gallate (EGCG) increases the viability of serum-starved A549 cells through its effect on Akt.
    Kim MJ, Kim HI, Chung J, Jeong TS, Park HR.
    Am J Chin Med; 2009; 37(4):723-34. PubMed ID: 19655410
    [Abstract] [Full Text] [Related]

  • 2. Epigallocatechin gallate protects nerve growth factor differentiated PC12 cells from oxidative-radical-stress-induced apoptosis through its effect on phosphoinositide 3-kinase/Akt and glycogen synthase kinase-3.
    Koh SH, Kim SH, Kwon H, Park Y, Kim KS, Song CW, Kim J, Kim MH, Yu HJ, Henkel JS, Jung HK.
    Brain Res Mol Brain Res; 2003 Oct 21; 118(1-2):72-81. PubMed ID: 14559356
    [Abstract] [Full Text] [Related]

  • 3. Phosphatidylinositol-3 kinase/Akt and GSK-3 mediated cytoprotective effect of epigallocatechin gallate on oxidative stress-injured neuronal-differentiated N18D3 cells.
    Koh SH, Kim SH, Kwon H, Kim JG, Kim JH, Yang KH, Kim J, Kim SU, Yu HJ, Do BR, Kim KS, Jung HK.
    Neurotoxicology; 2004 Sep 21; 25(5):793-802. PubMed ID: 15288510
    [Abstract] [Full Text] [Related]

  • 4. Epigallocatechin gallate prevents oxidative-stress-induced death of mutant Cu/Zn-superoxide dismutase (G93A) motoneuron cells by alteration of cell survival and death signals.
    Koh SH, Kwon H, Kim KS, Kim J, Kim MH, Yu HJ, Kim M, Lee KW, Do BR, Jung HK, Yang KW, Appel SH, Kim SH.
    Toxicology; 2004 Oct 01; 202(3):213-25. PubMed ID: 15337584
    [Abstract] [Full Text] [Related]

  • 5. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis.
    Lin SK, Chang HH, Chen YJ, Wang CC, Galson DL, Hong CY, Kok SH.
    Arthritis Rheum; 2008 Oct 01; 58(10):3145-56. PubMed ID: 18821707
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effects of (-)-epigallocatechin-3-gallate against quinolinic acid-induced excitotoxicity via PI3K pathway and NO inhibition.
    Jang S, Jeong HS, Park JS, Kim YS, Jin CY, Seol MB, Kim BC, Lee MC.
    Brain Res; 2010 Feb 08; 1313():25-33. PubMed ID: 20025854
    [Abstract] [Full Text] [Related]

  • 7. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
    He L, Zhang E, Shi J, Li X, Zhou K, Zhang Q, Le AD, Tang X.
    Cancer Chemother Pharmacol; 2013 Mar 08; 71(3):713-25. PubMed ID: 23292117
    [Abstract] [Full Text] [Related]

  • 8. Polyphenol epigallocatechin-3-gallate alleviates high glucose-induced H9C2 cell damage through PI3K/Akt pathway.
    Wang ZM, Zhong CY, Zhao GJ.
    Eur Rev Med Pharmacol Sci; 2017 Sep 08; 21(18):4236-4242. PubMed ID: 29028073
    [Abstract] [Full Text] [Related]

  • 9. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y, Zhao DY, Elliott S, Zhao W, Curiel TJ, Beckman BS, Burow ME.
    Int J Oncol; 2007 Oct 08; 31(4):705-11. PubMed ID: 17786300
    [Abstract] [Full Text] [Related]

  • 10. Study of EGCG induced apoptosis in lung cancer cells by inhibiting PI3K/Akt signaling pathway.
    Gu JJ, Qiao KS, Sun P, Chen P, Li Q.
    Eur Rev Med Pharmacol Sci; 2018 Jul 08; 22(14):4557-4563. PubMed ID: 30058690
    [Abstract] [Full Text] [Related]

  • 11. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis.
    Liu D, Li P, Song S, Liu Y, Wang Q, Chang Y, Wu Y, Chen J, Zhao W, Zhang L, Wei W.
    Eur J Pharmacol; 2012 Sep 05; 690(1-3):214-25. PubMed ID: 22760071
    [Abstract] [Full Text] [Related]

  • 12. Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K/AKT and Telomerase.
    Moradzadeh M, Hosseini A, Erfanian S, Rezaei H.
    Pharmacol Rep; 2017 Oct 05; 69(5):924-928. PubMed ID: 28646740
    [Abstract] [Full Text] [Related]

  • 13. Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.
    Yuan CH, Horng CT, Lee CF, Chiang NN, Tsai FJ, Lu CC, Chiang JH, Hsu YM, Yang JS, Chen FA.
    Environ Toxicol; 2017 Mar 05; 32(3):845-855. PubMed ID: 27200496
    [Abstract] [Full Text] [Related]

  • 14. Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation.
    Park SB, Bae JW, Kim JM, Lee SG, Han M.
    Int J Mol Med; 2012 Nov 05; 30(5):1211-8. PubMed ID: 22923012
    [Abstract] [Full Text] [Related]

  • 15. Epigallocatechin-3-gallate and zinc provide anti-apoptotic protection against hypoxia/reoxygenation injury in H9c2 rat cardiac myoblast cells.
    Zeng X, Tan X.
    Mol Med Rep; 2015 Aug 05; 12(2):1850-6. PubMed ID: 25872640
    [Abstract] [Full Text] [Related]

  • 16. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K, Kobayashi N, Inazawa Y, Zhang H, Nishitoh H, Ichijo H, Saeki K, Isemura M, Yuo A.
    Biochem J; 2002 Dec 15; 368(Pt 3):705-20. PubMed ID: 12206715
    [Abstract] [Full Text] [Related]

  • 17. Tea polyphenol epigallocatechin 3-gallate impedes the anti-apoptotic effects of low-grade repetitive stress through inhibition of Akt and NFkappaB survival pathways.
    Sen P, Chakraborty PK, Raha S.
    FEBS Lett; 2006 Jan 09; 580(1):278-84. PubMed ID: 16376342
    [Abstract] [Full Text] [Related]

  • 18. Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.
    Shen X, Zhang Y, Feng Y, Zhang L, Li J, Xie YA, Luo X.
    Int J Oncol; 2014 Mar 09; 44(3):791-6. PubMed ID: 24402647
    [Abstract] [Full Text] [Related]

  • 19. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH, Lin CC, Lin JK, Chen WJ.
    J Agric Food Chem; 2007 Jun 27; 55(13):5030-7. PubMed ID: 17539658
    [Abstract] [Full Text] [Related]

  • 20. Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways.
    Zhang T, Yang D, Fan Y, Xie P, Li H.
    Apoptosis; 2009 Oct 27; 14(10):1245-54. PubMed ID: 19669889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.